Trials / Completed
CompletedNCT01680497
Post-Market Study of JUVÉDERM VOLIFT™ With Lidocaine for the Correction of Nasolabial Folds
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
A prospective, open-label, multi-center, observational, post-market study evaluating JUVÉDERM VOLIFT™ for the correction of moderate to severe nasolabial folds
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Crosslinked hyaluronic acid dermal filler | All treatment details are at the discretion of the Investigator and should be guided by the Directions for Use. Up to 3 treatments will be administered: Initial treatment, optional top-up treatment at Day 14 post-initial treatment, and optional repeat treatment at Month 12 post-initial treatment. |
Timeline
- Start date
- 2012-06-01
- Primary completion
- 2014-03-06
- Completion
- 2014-03-06
- First posted
- 2012-09-07
- Last updated
- 2019-04-16
- Results posted
- 2015-06-23
Locations
3 sites across 2 countries: Germany, Netherlands
Source: ClinicalTrials.gov record NCT01680497. Inclusion in this directory is not an endorsement.